The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1378
November 28, 2011
View Complete Issue         Table of Contents 2019 
Once-Daily Gabapentin (Gralise) for Postherpetic Neuralgia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Once-Daily Gabapentin (Gralise) for Postherpetic Neuralgia
November 28, 2011 (Issue: 1378)
A new once-daily formulation of gabapentin (Gralise – Depomed) has been approved by the FDA for treatment of postherpetic neuralgia (PHN). Immediate-release (IR) gabapentin (Neurontin, and others), which has been available in the US since 1994,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Once-Daily Gabapentin (Gralise) for Postherpetic Neuralgia
Article code: 1378b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.